This site is intended for health professionals only

Published on 10 July 2007

Share this story:

COPD drug access widened


European regulators have expanded the number of patients eligible for treatment with GlaxoSmithKline’s chronic obstructive pulmonary disorder drug Seretide

Most read

Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story: